MoneyWorks4Me

Marksans Pharma informs about press release

07 Aug 2023 Evaluate
Marksans Pharma has informed that it enclosed press release titled ‘Marksaris announces completion of US FDA Post-marketing Adverse Drug Experience (PADE) inspection’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..